Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

The Biggest News of 2019: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

January 01, 2020

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

News Conference News ESC 2019

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

Yael L. Maxwell

September 12, 2019

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

News Daily News

Renal Denervation for Chagas Disease-Related HF Proves Safe in Pilot Study

August 01, 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

March 11, 2019

Multivessel Disease: Should Invasive Physiology Change My Strategy?

Presentation TCT 2018

Multivessel Disease: Should Invasive Physiology Change My Strategy?

Presenter: Anibal A. Damonte, Jacques Monsegu, Eric Van Belle

September 24, 2018

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

News Daily News

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

September 21, 2017

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

April 08, 2016

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

August 31, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.